To advance collaborative discovery and support the next generation of research leaders, University Hospitals and Case Western Reserve University School of Medicine have jointly awarded funding to six research teams through the 2026 Collaborative Science Pilot Awards.  Each project received $50,000 for a year of funding. Since launching in 2023, the program has supported 14 research teams with a total investment of $700,000.

Circadian rhythms play a crucial role in regulating various physiological processes. A recent review highlights the critical role of circadian rhythms in muscle health and aging, emphasizing how circadian disruption contributes to sarcopenia. Researchers propose circadian-aligned lifestyle interventions and pharmacological treatments as potential strategies to combat age-related muscle loss, offering new avenues for sarcopenia management in the elderly.

ARDD 2026 has announced that George Church, Professor at Harvard Medical School, will speak at the 13th Aging Research & Drug Discovery (ARDD) Meeting, taking place October 1–3, 2026, at the David Rubenstein Treehouse at Harvard University. As the world's leading conference dedicated to longevity biotechnology, ARDD 2026 will convene top researchers, pharmaceutical executives, entrepreneurs, and investors to accelerate the translation of aging science into next-generation medicines.

Organized by Insilico Medicine and supported by industry leaders including Eli Lilly and the McKinsey Health Institute, the meeting reflects the growing momentum behind longevity as a major frontier in biomedical innovation. With speakers representing ten of the world's leading pharmaceutical companies, ARDD 2026 aims to foster the collaborations needed to transform discoveries in aging biology into therapies that extend healthy lifespan and improve patient outcomes.